Dual effect of AMD3100, a CXCR4 antagonist, on bleomycin-induced lung inflammation

Journal of Immunology

Volumn 178, Issue 9, 2007, Pages 5888-5898

  Watanabe, Masaki ^a   Matsuyama, Wataru ^a   Shirahama, Yuko ^a   Mitsuyama, Hideo ^a   Oonakahara, Ken Ichi ^a   Noma, Satoshi ^a   Higashimoto, Ikkou ^a   Osame, Mitsuhiro ^a   Arimura, Kimiyoshi ^a  

^a KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE); 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; BLEOMYCIN; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG MECHANISM; FEMALE; FLOW CYTOMETRY; INFLAMMATORY CELL; LUNG FIBROSIS; LUNG LAVAGE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL;

EID: 34247570897     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.9.5888     Document Type: Article

References (62)

1. Zlotnik, A., and O. Yoshie. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127.
2. Rossi, D., and A. Zlotnik. 2000. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18: 217-242.
3. + progenitors to peripheral blood. J. Exp. Med. 185: 111-120.
4. Bleul, C. C., R. C. Fuhlbrigge, J. M. Casasnovas, A. Aiuti, and T. A. Springer. 1996. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184: 1101-1109.
5. Mizuno, K., W. Matsuyama, H. Mitsuyama, M. Watanabe, I. Higashimoto, M. Osame, and K. Arimura. 2005. Clinical investigation: increased serum stromal derived factor la levels in pulmonary tuberculosis. Clin. Exp. Immunol. 139: 490-497.
6. Nagase, H., M. Miyamasu, M. Yamaguchi, T. Fujisawa, K. Ohta, K. Yamamoto, Y. Morita, and K. Hirai. 2000. Expression of CXCR4 in eosinophils: functional analyses and cytokine-mediated regulation. J. Immunol. 164: 5935-5943.
7. Baggiolini, M., B. Dewald, and B. Moser. 1997. Human chemokines: an update. Annu. Rev. Immunol. 15: 675-705.
8. Rollins, B. J. 1997. Chemokines. Blood 90: 909-928.
9. Charnaux, N., S. Brule, M. Hamon, T. Chaigneau, L. Saffar, C. Prost, N. Lievre, and L. Gattegno. 2005. Syndecan-4 is a signaling molecule for stromal cell-derived factor-1 (SDF-1)/CXCL12. FEBS J. 272: 1937-1951.
10. Burns, J. M., B. C. Summers, Y. Wang, A. Melikian, R. Berahovich, Z. Miao, M. E. Penfold, M. J. Sunshine, D. R. Littman, C. J. Kuo, et al. 2006. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J. Exp. Med. 203: 2201-2213.
11. Bleul, C. C., M. Farzan, H. Choe, C. Parolin, I. Clark-Lewis, J. Sodroski, and T. A. Springer. 1996. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382: 829-833.
12. Nagasawa, T., S. Hirota, K. Tachibana, N. Takakura, S. Nishikawa, Y. Kitamura, N. Yoshida, H. Kikutani, and T. Kishimoto. 1996. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382: 635-638.
13. Zou, Y. R., A. H. Kottmann, M. Kuroda, I. Taniuchi, and D. R. Littman. 1998. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393: 595-599.
14. Oonakahara, K., W. Matsuyama, I. Higashimoto, M. Kawabata, K. Arimura, and M. Osame. 2004. Stromal-derived factor-1α/CXCL12-CXCR 4 axis is involved in the dissemination of NSCLC cells into pleural space. Am. J. Respir. Cell Mol. Biol. 30: 671-677.
15. Yousefi, S., P. R. Cooper, S. L. Potter, B. Mueck, and G. Jarai. 2001. Cloning and expression analysis of a novel G-protein-coupled receptor selectively expressed on granulocytes. J. Leukocyte Biol. 69: 1045-1052.
16. Lenoir, M., B. Djerdjouri, and A. Perianin. 2004. Stroma cell-derived factor 1α mediates desensitization of human neutrophil respiratory burst in synovial fluid from rheumatoid arthritic patients. J. Immunol. 172: 7136-7143.
17. Link, D. C. 2005. Neutrophil homeostasis: a new role for stromal cell-derived factor-1. Immunol. Res. 32: 169-178.
18. De Clercq, E., N. Yamamoto, R. Pauwels, M. Baba, D. Schols, H. Nakashima, J. Balzarini, Z. Debyser, B. A. Murrer, and D. Schwartz. 1992. Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event. Proc. Natl. Acad. Sci. USA 89: 5286-5290.
19. Hendrix, C. W., C. Flexner, R. T. MacFarland, C. Giandomenico, E. J. Fuchs, E. Redpath, G. Bridger, and G. W. Henson. 2000. Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob. Agents Chemother. 44: 1667-1673.
20. Schols, D., S. Struyf, J. Van Damme, J. A. Este, G. Henson, and E. De Clercq. 1997. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J. Exp. Med. 186: 1383-1388.
21. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272: 872-877.
22. Matthys, P., S. Hatse, K. Vermeire, A. Wuyts, G. Bridger, G. W. Henson, E. De Clercq, A. Billiau, and D. Schols. 2001. AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-γ receptor-deficient mice. J. Immunol. 167: 4686-4692.
23. Lukacs, N. W., A. Berlin, D. Schols, R. T. Skerlj, and G. J. Bridger. 2002. AMD3100, a CxCR4 antagonist, attenuates allergic lung inflammation and airway hyperreactivity. Am. J. Pathol. 160: 1353-1360.
24. De Klerck, B., L. Geboes, S. Hatse, H. Kelchtermans, Y. Meyvis, K. Vermeire, G. Bridger, A. Billiau, D. Schols, and P. Matthys. 2005. Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritis. Arthritis Res. Ther. 7: R1208-R1220.
25. Ashcroft, T., J. M. Simpson, and V. Timbrell. 1988. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol. 41: 467-470.
26. Matsuyama, W., M. Watanabe, Y. Shirahama, R. Hirano, H. Mitsuyama, I. Higashimoto, M. Osame, and K. Arimura. 2006. Suppression of discoidin domain receptor 1 by RNA interference attenuates lung inflammation. J. Immunol. 176: 1928-1936.
27. Matsuyama, W., M. Watanabe, Y. Shirahama, K. Oonakahara, I. Higashimoto, T. Yoshimura, M. Osame, and K. Arimura. 2005. Activation of discoidin domain receptor 1 on CD 14-positive bronchoalveolar lavage fluid cells induces chemokine production in idiopathic pulmonary fibrosis. J. Immunol. 174: 6490-6498.
28. Nick, J. A., S. K. Young, K. K. Brown, N. J. Avdi, P. G. Arndt, B. T. Suratt, M. S. Janes, P. M. Henson, and G. S. Worthen. 2000. Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation. J. Immunol. 164: 2151-2159.
29. Wang, J., J. Wang, Y. Sun, W. Song, J. E. Nor, C. Y. Wang, and R. S. Taichman. 2005. Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis. Cell. Signal. 17: 1578-1592.
30. Smith, M. C., K., E. Luker, J. R. Garbow, J. L. Prior, E. Jackson, D. Piwnica-Worms, and G. D. Luker. 2004. CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res. 64: 8604-8612.
31. Azoulay, E., S. Herigault, M. Levame, L. Brochard, B. Schlemmer, A. Half, and C. Delclaux. 2003. Effect of granulocyte colony-stimulating factor on bleomycin-induced acute lung injury and pulmonary fibrosis. Crit. Care Med. 31: 1442-1448.
32. Kim, K. H., K. Burkhart, P. Chen, C. W. Frevert, J. Randolph-Habecker, R. C. Hackman, P. D. Soloway, and D. K. Madtes. 2005. Tissue inhibitor of metalloproteinase-1 deficiency amplifies acute lung injury in bleomycin-exposed mice. Am. J. Respir. Cell Mol. Biol. 33: 271-279.
33. Lawson, W. E., V. V. Polosukhin, G. T. Stathopoulos, O. Zoia, W. Han, K. B. Lane, B. Li, E. F. Donnelly, G. E. Holburn, K. G. Lewis, et al. 2005. Increased and prolonged pulmonary fibrosis in surfactant protein C-deficient mice following intratracheal bleomycin. Am. J. Pathol. 167: 1267-1277.
34. Li, Q., P. W. Park, C. L. Wilson, and W. C. Parks. 2002. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111: 635-646.
35. Okuma, T., Y. Terasaki, K. Kaikita, H. Kobayashi, W. A. Kuziel, M. Kawasuji, and M. Takeya. 2004. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases. J. Pathol. 204: 594-604.
36. Khalil, N., C. Whitman, L. Zuo, D. Danielpour, and A. Greenberg. 1993. Regulation of alveolar macrophage transforming growth factor-β secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. J. Clin. Invest. 92: 1812-1818.
37. Smith, R. E., R. M. Strieter, K. Zhang, S. H. Phan, T. J. Standiford, N. W. Lukacs, and S. L. Kunkel. 1995. A role for C-C chemokines in fibrotic lung disease. J. Leukocyte Biol. 57: 782-787.
38. Suga, M., K. Iyonaga, H. Ichiyasu, N. Saita, H. Yamasaki, and M. Ando. 1999. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases. Eur. Respir. J. 14: 376-382.
39. Iyonaga, K., M. Takeya, N. Saita, O. Sakamoto, T. Yoshimura, M. Ando, and K. Takahashi. 1994. Monocyte chemoattractant protein-1 in idiopathic pulmonary fibrosis and other interstitial lung diseases. Hum. Pathol. 25: 455-463.
40. Antoniades, H. N., J. Neville-Golden, T. Galanopoulos, R. L. Kradin, A. J. Valente, and D. T. Graves. 1992. Expression of monocyte chemoattractant protein 1 mRNA in human idiopathic pulmonary fibrosis. Proc. Natl. Acad. Sci. USA 89: 5371-5375.
41. Inoshima, I., K. Kuwano, N. Hamada, N. Hagimoto, M. Yoshimi, T. Maeyama, A. Takeshita, S. Kitamoto, K. Egashira, and N. Hara. 2004. Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice. Am J. Physiol. 286: L1038-L1044.
42. McColl, S. R., and I. Clark-Lewis. 1999. Inhibition of murine neutrophil recruitment in vivo by CXC chemokine receptor antagonists. J. Immunol. 163: 2829-2835.
43. Keane, M. P., J. A. Belperio, T. A. Moore, B. B. Moore, D. A. Arenberg, R. E. Smith, M. D. Burdick, S. L. Kunkel, and R. M. Strieter. 1999. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. J. Immunol. 162: 5511-5518.
44. Cook, D. N., M. A. Beck, T. M. Coffman, S. L. Kirby, J. F. Sheridan, I. B. Pragnell, and O. Smithies. 1995. Requirement of MIP-1α for an inflammatory response to viral infection. Science 269: 1583-1585.
45. Smith, R. E., R. M. Strieter, S. H. Phan, N. Lukacs, and S. L. Kunkel. 1998. TNF and IL-6 mediate MIP-1α expression in bleomycin-induced lung injury. J. Leukocyte Biol. 64: 528-536.
46. Pittet, J. F., M. J. Griffiths, T. Geiser, N. Kaminski, S. L. Dalton, X. Huang, L. A. Brown, P. J. Gotwals, V. E. Koteliansky, M. A. Matthay, and D. Sheppard. 2001. TGF-β is a critical mediator of acute lung injury. J. Clin. Invest. 107: 1537-1544.
47. Khalil, N., and A. H. Greenberg. 1991. The role of TGF-β in pulmonary fibrosis. Ciba Found. Symp. 157: 194-207.
48. Zhang, K., K. C. Flanders, and S. H. Phan. 1995. Cellular localization of transforming growth factor-β expression in bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 147: 352-361.
49. Matsuoka, H., T. Arai, M. Mori, S. Goya, H. Kida, H. Morishita, H. Fujiwara, I. Tachibana, T. Osaki, and S. Hayashi. 2002. A p38 MAPK inhibitor, FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosis. Am. J. Physiol. 283: L103-L112.
50. Matsuyama, W., L. Wang, W. L. Farrar, M. Faure, and T. Yoshimura. 2004. Activation of discoidin domain receptor 1 isoform b with collagen up-regulates chemokine production in human macrophages: role of p38 mitogen-activated protein kinase and NF-κB. J. Immunol. 172: 2332-2340.
51. Lee, V. Y., C. Schroedl, J. K. Brunelle, L. J. Buccellato, O. I. Akinci, H. Kaneto, C. Snyder, J. Eisenbart, G. R. Budinger, and N. S. Chandel. 2005. Bleomycin induces alveolar epithelial cell death through JNK-dependent activation of the mitochondrial death pathway. Am J. Physiol. 289: L521-L528.
52. Grinstein, S., J. R. Butler, W. Furuya, G. L'Allemain, and G. P. Downey. 1994. Chemotactic peptides induce phosphorylation and activation of MEK-1 in human neutrophils. J. Biol. Chem. 269: 19313-19320.
53. Lee, H. S., H. J. Kim, C. S. Moon, Y. H. Chong, and J. L. Kang. 2004. Inhibition of c-Jun NH2-terminal kinase or extracellular signal-regulated kinase improves lung injury. Respir. Res. 5: 23.
54. Jozsef, L., T. Khreiss, A. Fournier, J. S. Chan, and J. G. Filep. 2002. Extracellular signal-regulated kinase plays an essential role in endothelin-1-induced homotypic adhesion of human neutrophil granulocytes. Br. J. Pharmacol. 135: 1167-1174.
55. Klein, J. B., M. J. Rane, J. A. Scherzer, P. Y. Coxon, R. Kettritz, J. M. Mathiesen, A. Buridi, and K. R. McLeish. 2000. Granulocyte-macrophage colony-stimulating factor delays neutrophil constitutive apoptosis through phosphoinositide 3-kinase and extracellular signal-regulated kinase pathways. J. Immunol. 164: 4286-4291.
56. Xiao, Y. Q., K. Someya, H. Morita, K. Takahashi, and K. Ohuchi. 1999. Involvement of p38 MAPK and ERK/MAPK pathways in staurosporine-ihduced production of macrophage inflammatory protein-2 in rat peritoneal neutrophils. Biochim. Biophys. Acta 1450: 155-163.
57. Marshall, R. P., R. J. McAnulty, and G. J. Laurent. 2000. Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am. J. Respir. Crit. Care Med. 161: 1999-2004.
58. Sun, Y., J. Q. Zhang, J. Zhang, and F. J. Ramires. 1998. Angiotensin II, transforming growth factor-β1 and repair in the infarcted heart. J. Mol. Cell. Cardiol. 30: 1559-1569.
59. Wang, R., O. Ibarra-Sunga, L. Verlinski, R. Pick, and B. D. Uhal. 2000. Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am. J. Physiol. 279: L143-L151.
60. Day, R. M., Y. Yang, Y. J. Suzuki, J. Stevens, R. Pathi, A. Perlmutter, B. L. Fanburg, and J. J. Lanzillo. 2001. Bleomycin up-regulates gene expression of angiotensin-converting enzyme via mitogen-activated protein kinase and early growth response 1 transcription factor. Am. J. Respir. Cell Mol. Biol. 25: 613-619.
61. Donzella, G. A., D. Schols, S. W. Lin, J. A. Este, K. A. Nagashima, P. J. Maddon, G. P. Allaway, T. P. Sakmar, G. Henson, E. De Clercq, and J. P. Moore. 1998. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nat. Med. 4: 12-11.
62. Phillips, R. J., M. D. Burdick, K. Hong, M. A. Lutz, L. A. Murray, Y. Y. Xue, J. A. Belperio, M. P. Keane, and R. M. Strieter. 2004. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J. Clin. Invest. 114: 438-446.